Elicio Therapeutics Inc — Stato Patrimoniale (NASDAQ:ELTX) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 96.51 M52.79 M27.15 M28.18 M25.86 M Totale passività 15.01 M9.02 M15.77 M39.49 M24.23 M Patrimonio netto totale 81.51 M43.77 M11.37 M-11.31 M1.64 M Totale passività e patrimonio netto 96.51 M52.79 M27.15 M28.18 M25.86 M Debito totale 58 K——20.03 M9.41 M Indebitamento netto -88.7 M——2.42 M-9.16 M

Notizie

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Elicio Therapeutics lancia una nuova offerta azionaria at-the-market da 100 milioni di dollari

H.C. Wainwright alza il target su Elicio Therapeutics a 17$

H.C. Wainwright raises Elicio Therapeutics price target to $17

Rodman & Renshaw avvia la copertura su Elicio Therapeutics con rating buy

Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating

Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why

Elicio riporta diffusione antigenica nell’87% dei pazienti oncologici valutati

Elicio reports antigen spreading in 87% of evaluated cancer patients

Elicio Therapeutics nomina Marc Wolfgang come Chief Technology Officer

Elicio Therapeutics appoints Marc Wolfgang as chief technology officer